Total Payments
$1,755
2024 Payments
$95.53
Companies
10
Transactions
37
Medicare Patients
3,662
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$1,740 (99.2%)
Education$14.66 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,740 | 36 | 99.2% |
| Education | $14.66 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $460.16 | 15 | $0 (2024) |
| Allergan Inc. | $422.77 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $334.06 | 5 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $137.96 | 2 | $0 (2022) |
| Shire North American Group Inc | $105.98 | 1 | $0 (2018) |
| Alcon Vision LLC | $101.68 | 1 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $71.84 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $61.84 | 2 | $0 (2024) |
| Genentech, Inc. | $44.10 | 1 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $14.65 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.53 | 3 | Astellas Pharma US Inc ($61.84) |
| 2023 | $58.86 | 2 | Genentech USA, Inc. ($58.86) |
| 2022 | $65.19 | 5 | Genentech USA, Inc. ($35.88) |
| 2021 | $231.20 | 2 | Regeneron Healthcare Solutions, Inc. ($123.30) |
| 2020 | $83.87 | 3 | Genentech, Inc. ($44.10) |
| 2019 | $340.81 | 5 | Novartis Pharmaceuticals Corporation ($135.92) |
| 2018 | $659.09 | 12 | Allergan Inc. ($217.59) |
| 2017 | $220.49 | 5 | Allergan Inc. ($114.06) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Ophthalmology | ||||||
| 08/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/27/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/08/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $20.48 | General |
| 04/21/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Education | In-kind items and services | $14.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/21/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/28/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/15/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $123.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/15/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $107.90 | General |
| Category: Ophthalmology | ||||||
| 03/11/2020 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $44.10 | General |
| Category: Ophthalmology | ||||||
| 02/10/2020 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/08/2020 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Ophthalmology | ||||||
| 11/14/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Ophthalmology | ||||||
| 11/06/2019 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $101.68 | General |
| Category: Ophthalmology | ||||||
| 10/12/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | Cash or cash equivalent | $79.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/28/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $91.12 | General |
| Category: RETINA | ||||||
| 01/08/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $56.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/07/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Ophthalmology | ||||||
| 11/13/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/20/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug), BROLUCIZUMAB | Food and Beverage | In-kind items and services | $88.68 | General |
| 09/12/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $113.18 | General |
| 09/10/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 367 | 1,071 | $494,879 | $220,582 |
| 2022 | 8 | 277 | 797 | $299,459 | $187,116 |
| 2021 | 5 | 94 | 183 | $32,131 | $13,698 |
| 2020 | 18 | 2,924 | 13,599 | $6.4M | $3.3M |
Total Patients
3,662
Total Services
15,650
Medicare Billing
$3.7M
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 17 | 248 | $372,000 | $167,745 | 45.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 43 | 204 | $40,800 | $19,372 | 47.5% |
| 92134 | Imaging of retina | Office | 2023 | 124 | 341 | $25,575 | $10,007 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $20,100 | $7,371 | 36.7% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 21 | 78 | $10,100 | $6,282 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 55 | $13,200 | $4,962 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 78 | $13,104 | $4,843 | 37.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 13 | 204 | $206,941 | $145,857 | 70.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 25 | 142 | $28,400 | $14,245 | 50.2% |
| 92134 | Imaging of retina | Office | 2022 | 90 | 238 | $17,850 | $7,385 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $18,300 | $6,674 | 36.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 16 | 64 | $7,900 | $4,957 | 62.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 38 | $9,120 | $3,606 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 36 | $6,048 | $2,204 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $4,900 | $2,188 | 44.6% |
| 67028 | Injection of drug into eye | Office | 2021 | 13 | 60 | $12,107 | $5,896 | 48.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $9,774 | $3,535 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 20 | $4,800 | $2,056 | 42.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 28 | 59 | $4,356 | $1,809 | 41.5% |
| 92250 | Photography of the retina | Office | 2021 | 11 | 13 | $1,094 | $402.37 | 36.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2020 | 220 | 5,498 | $2.6M | $1.5M | 56.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 153 | 1,814 | $2.3M | $1.3M | 59.1% |
| 67028 | Injection of drug into eye | Office | 2020 | 540 | 2,346 | $777,812 | $177,756 | 22.9% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2020 | 31 | 312 | $144,300 | $76,024 | 52.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 184 | 780 | $90,944 | $46,200 | 50.8% |
About Dr. Yasser Elshatory, MD
Dr. Yasser Elshatory, MD is a Ophthalmology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1033403100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yasser Elshatory, MD has received a total of $1,755 in payments from pharmaceutical and medical device companies, with $95.53 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,740).
As a Medicare-enrolled provider, Elshatory has provided services to 3,662 Medicare beneficiaries, totaling 15,650 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Plano, TX
- Active Since 06/06/2011
- Last Updated 12/16/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1033403100
Products in Payments
- Lucentis (Biological) $375.83
- OZURDEX (Drug) $286.24
- BEOVU (Drug) $154.79
- EYLEA (Biological) $137.96
- XIIDRA (Drug) $105.98
- AcrySof (Device) $101.68
- Vabysmo (Drug) $92.55
- BROLUCIZUMAB (Drug) $88.68
- Bromsite (Drug) $71.84
- Izervay (Drug) $61.84
- LUMIGAN (Drug) $23.35
- SUSVIMO (Drug) $15.40
- ACTHAR (Biological) $14.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Plano
Dr. Hemang Pandya, M.d, M.D
Ophthalmology — Payments: $157,577
Ophthalmology $157,577
Dr. Dain Brooks, Md, MD
Ophthalmology — Payments: $18,457
Ophthalmology $18,457
Shashi Alloju, Md, MD
Ophthalmology — Payments: $9,917
Ophthalmology $9,917
Dr. Connor Smith, M.d, M.D
Ophthalmology — Payments: $5,615
Ophthalmology $5,615
Dr. Abdulfatah Ali, M.d, M.D
Ophthalmology — Payments: $5,205
Ophthalmology $5,205
Patricia Fortin, Md, MD
Ophthalmology — Payments: $4,253
Ophthalmology $4,253